loading page

Management strategy of an inpatient requiring urgent coronary artery revascularisation with prolonged SARS-CoV-2 shedding
  • +4
  • Dharsicka Nadarajah,
  • Sundeep Kaul,
  • Anne Hall,
  • Paras Dalal,
  • Tito Kabir,
  • Ulrich Stock,
  • Jaymin Morjaria
Dharsicka Nadarajah
Royal Brompton and Harefield NHS Trust
Author Profile
Sundeep Kaul
Royal Brompton and Harefield NHS Trust
Author Profile
Anne Hall
Royal Brompton and Harefield NHS Trust
Author Profile
Paras Dalal
Royal Brompton and Harefield NHS Trust
Author Profile
Tito Kabir
Royal Brompton and Harefield NHS Trust
Author Profile
Ulrich Stock
Royal Brompton and Harefield NHS Foundation Trust
Author Profile
Jaymin Morjaria
Royal Brompton and Harefield NHS Trust
Author Profile

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in China, is the cause of the global pandemic Coronavirus Disease 19 (Covid-19). To date, there is no widely available vaccine or treatment, hence containment strategies are currently centred around measures ameliorating human transmission via social distancing and quarantine. Due to the magnitude of the pandemic, elective operative work had ceased within cardiac surgery at our institution and strategies adapted to facilitate safe management of surgical candidates. Here, we present the case report of an asymptomatic inpatient with prolonged viral shedding on real-time polymerase chain reaction (RT-PCR) on oropharyngeal swabs who required urgent coronary artery revascularisation, and the lessons learnt from the adapted management strategy deployed for revascularisation during the COVID-19 pandemic.